The company’s short term price target estimate is $29, according to the report. On the low end, the price target could be $12. On the high end, the price target could be $37, according to the report.
Exact Sciences has a market cap of $2.03 billion.
More articles on gastroenterology:
8 payment updates for gastroenterologists to know
FDA sends warning letters to 3 major scope manufacturers
Company behind Cologuard wins innovation award
